Structures by: Thiruvenkatam V.
Total: 22
C17H16N2O
C17H16N2O
New J. Chem. (2016) 40, 5 4588
a=16.9790(10)Å b=10.3445(9)Å c=15.9847(10)Å
α=90° β=90° γ=90°
Gefitinib methanol hemisolvate
C22H24ClFN4O3,0.5(CH4O)
Acta Crystallographica Section C (2018) 74, 8
a=7.337(2)Å b=10.991(3)Å c=27.078(8)Å
α=98.241(9)° β=91.151(10)° γ=91.244(9)°
Xanthenedione
C23H26O4
Acta Crystallographica Section C (2018) 74, 7
a=12.251(6)Å b=14.971(8)Å c=10.868(6)Å
α=90° β=95.289(9)° γ=90°
Xanthenedione
C24H27BrO4
Acta Crystallographica Section C (2018) 74, 7
a=20.6531(14)Å b=9.5629(7)Å c=22.4489(16)Å
α=90° β=90° γ=90°
Xanthenedione
C22H25NO3
Acta Crystallographica Section C (2018) 74, 7
a=9.2893(11)Å b=10.0558(12)Å c=22.911(3)Å
α=83.057(2)° β=85.272(2)° γ=64.888(2)°
Ethyl 5-phenylisoxazole-3-carboxylate
C12H11NO3
Acta Crystallographica Section E (2017) 73, 4 531-534
a=5.4447(7)Å b=17.180(2)Å c=11.7603(19)Å
α=90° β=94.508(5)° γ=90°
Inositol Derivative
C12H20O6,2(H2O)
Acta crystallographica. Section C, Structural chemistry (2017) 73, Pt 1 20-27
a=38.459(3)Å b=8.6208(7)Å c=8.2420(7)Å
α=90° β=95.371(2)° γ=90°
(4-methoxyphenyl)thiourea
C15H16N2O2S
Acta Crystallographica Section E (2006) 62, 4 o1518-o1519
a=8.427(5)Å b=31.628(19)Å c=5.292(3)Å
α=90° β=90° γ=90°
Pyrimethamine hydrogen adipate
C12H14ClN4,C6H9O4
Acta Crystallographica Section E (2007) 63, 10 o4065-o4066
a=8.1540(10)Å b=11.420(2)Å c=12.238(2)Å
α=79.38(2)° β=71.06(2)° γ=71.20(2)°
2-Ethoxy-4-methylphenyl p-toluenesulfonate
C16H18O4S
Acta Crystallographica Section E (2007) 63, 12 o4638-o4638
a=7.8095(10)Å b=9.2787(12)Å c=11.4058(15)Å
α=104.678(2)° β=99.653(2)° γ=94.906(2)°
Tetrahydrocurcumin
C21H24O6
Acta Crystallographica Section C (2004) 60, 8 o611-o613
a=7.981(3)Å b=11.388(3)Å c=12.497(3)Å
α=117.065(3)° β=100.394(10)° γ=94.856(3)°
Glycinium oxalate (2:1)
2C2H6NO2,C2O42
Acta Crystallographica Section C (2006) 62, 5 o274-o276
a=4.9199(18)Å b=9.959(4)Å c=10.859(4)Å
α=90.00° β=97.513(5)° γ=90.00°
Bis(glycyl-L-aspartic acid) oxalate 0.4-hydrate
2(C6H11N2O5),C2O42,0.4(H2O)
Acta Crystallographica Section C (2007) 63, 1 o11-o13
a=4.8100(8)Å b=10.7760(18)Å c=10.8756(18)Å
α=69.325(3)° β=85.792(3)° γ=81.946(3)°
C22H35Cl2CoN6O7.5
C22H35Cl2CoN6O7.5
ACS Catalysis (2019) 10115
a=13.559(2)Å b=15.380(2)Å c=15.989(3)Å
α=63.668(5)° β=88.605(7)° γ=74.638(6)°
C21H33Cl2CoN6O6
C21H33Cl2CoN6O6
ACS Catalysis (2019) 10115
a=15.4342(10)Å b=23.908(3)Å c=16.1767(12)Å
α=90° β=117.903(2)° γ=90°
C6H6FN
C6H6FN
Crystal Growth & Design (2006) 6, 4 843
a=10.755(7)Å b=5.419(4)Å c=9.046(6)Å
α=90° β=90° γ=90°
C6H5FN
C6H5FN
Crystal Growth & Design (2006) 6, 4 843
a=16.347(13)Å b=11.142(13)Å c=9.425(9)Å
α=90° β=103.36(2)° γ=90°
C8H4F4O
C8H4F4O
Crystal Growth & Design (2007) 7, 5 868
a=10.456(3)Å b=9.592(3)Å c=7.806(2)Å
α=90° β=102.790(5)° γ=90°
C8H4ClF3O
C8H4ClF3O
Crystal Growth & Design (2007) 7, 5 868
a=7.478(3)Å b=9.884(4)Å c=11.222(5)Å
α=90° β=90° γ=90°
C8H4BrF3O
C8H4BrF3O
Crystal Growth & Design (2007) 7, 5 868
a=11.862(10)Å b=10.237(9)Å c=7.298(6)Å
α=90° β=101.110(15)° γ=90°
C8H4BrF3O
C8H4BrF3O
Crystal Growth & Design (2007) 7, 5 868
a=4.5037(17)Å b=14.915(6)Å c=12.927(5)Å
α=90° β=90.456(6)° γ=90°
C8H4F3NO3
C8H4F3NO3
Crystal Growth & Design (2007) 7, 5 868
a=11.838(3)Å b=6.7278(17)Å c=10.692(3)Å
α=90° β=90° γ=90°